Displaying items by tag: department of neurology

The study, utilizing the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease.
The AHEAD study is looking to recruit people at risk for developing Alzheimer’s disease for a new study.
The gift will advance the use of induced pluripotent stem cells as a potential therapy for Alzheimer’s disease.
An internationally recognized clinician and researcher in Parkinson’s disease, UAB’s David Standaert, M.D., Ph.D., has been honored with a lifetime achievement award from the Parkinson’s Association of Alabama.
The new technique to predict seizure clusters could, if confirmed, have a profound impact on patients with drug-resistant epilepsy who are prone to seizure clusters. 
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.
Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.
With the number of Americans with dementia expected to increase dramatically, UAB’s new brain health clinics point the way to improving brain health over a lifespan.
Adeel Memon will be the first graduate of the UAB neuroengineering Ph.D. program during the 2022 spring graduate commencement ceremony on April 29.
The investigational drug masitinib appears to inhibit parts of the immune system that may be overactive in ALS.
The fields of neuroengineering and brain-computer interfaces could have a tremendous impact on a number of neurologic conditions, such as stroke, neurodegenerative disorders, Parkinson’s disease, dementia and other brain diseases.
Consortium led by UAB researchers in the UAB Heersink School of Medicine and School of Public Health received additional funding to further study chronic hypertension and preeclampsia epigenetics participants enrolled in the CHAP trial.
Modeled on the state’s trauma system, the Alabama Statewide Stroke System will help improve emergency response for stroke patients.

The PPMI study is looking for biomarkers for Parkinson’s disease, which would help identify those at risk and track the progression of the disease.

Recent studies have shown that formal exercise training can help boost memory, and memory deficit is relatively common in people with epilepsy.

The grant links researchers from different disciplines, institutions and locations to study basic mechanisms that contribute to Parkinson’s disease.

UAB’s Standaert elected vice president of a leading neurological professional organization.

The new grant links UAB researchers with colleagues at two other institutions to search for ways to advance therapies from bench to bedside.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
Page 1 of 12